login
login

Europe Daily Bulletin No. 13098

13 January 2023
INSTITUTIONAL / Lobbying
Covid-19 Special Committee wants to withdraw right of access to European Parliament from Pfizer’s CEO, Albert Bourla
Brussels, 12/01/2023 (Agence Europe)

The coordinators of the European Parliament’s Special Committee on ‘Covid’ adopted, on Wednesday 11 January, a request from the Greens/EFA group to suspend the access of Albert Bourla, CEO of the pharmaceutical company Pfizer, to the European Parliament.

Mr Bourla had first cancelled his participation in a hearing with the committee, which wanted to question him in particular on the contracts for the supply of vaccines against Covid-19(see EUROPE B13039A13). Mr Bourla was replaced at...

Contents

SECTORAL POLICIES
INSTITUTIONAL
Russian invasion of Ukraine
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
SOCIAL AFFAIRS - EMPLOYMENT
ECONOMY - FINANCE - BUSINESS
COURT OF JUSTICE OF THE EU
NEWS BRIEFS